Clinical Trial Update: Tipifarnib in Treating Young Patients With Refractory Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing Tipifarnib in young patients with refractory leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Leukemia | Phase 1 | Status: COMPLETED